SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Marta Martinez-Vicente, Autophagy in neurodegenerative diseases: From pathogenic dysfunction to therapeutic modulation, Seminars in Cell & Developmental Biology, 2015, 40, 115

    CrossRef

  2. 2
    Michael J. Hurley, Steve M. Gentleman, David T. Dexter, Calcium CaV1 Channel Subtype mRNA Expression in Parkinson’s Disease Examined by In Situ Hybridization, Journal of Molecular Neuroscience, 2015, 55, 3, 715

    CrossRef

  3. 3
    Emily M. Rocha, Gaynor A. Smith, Eric Park, Hongmei Cao, Anne-Renee Graham, Eilish Brown, Jesse R. McLean, Melissa A. Hayes, Jonathan Beagan, Sarah C. Izen, Eduardo Perez-Torres, Penelope J. Hallett, Ole Isacson, Chronic pharmacological glucocerebrosidase inhibition induces α-synuclein aggregation, microglial and complement activation and synaptic protein changes in mice, Antioxidants & Redox Signaling, 2015, 150621044325006

    CrossRef

  4. 4
    Anuj K. Yadav, David L. Shen, Xiaoyang Shan, Xu He, Allison R. Kermode, David J. Vocadlo, Fluorescence-Quenched Substrates for Live Cell Imaging of Human Glucocerebrosidase Activity, Journal of the American Chemical Society, 2015, 137, 3, 1181

    CrossRef

  5. You have free access to this content5
    Timothy M. Cox, Barry E. Rosenbloom, Roger A. Barker, Gaucher disease and comorbidities: B-cell malignancy and parkinsonism, American Journal of Hematology, 2015, 90,
  6. 6
    Yaqiong Li, Ping Li, Huimin Liang, Zhiquan Zhao, Makoto Hashimoto, Jianshe Wei, Gaucher-Associated Parkinsonism, Cellular and Molecular Neurobiology, 2015,

    CrossRef

  7. 7
    S. Pablo Sardi, Seng H. Cheng, Lamya S. Shihabuddin, Gaucher-related synucleinopathies: The examination of sporadic neurodegeneration from a rare (disease) angle, Progress in Neurobiology, 2015, 125, 47

    CrossRef

  8. 8
    Kathrin Brockmann, Karin Srulijes, Sylvia Pflederer, Ann-Kathrin Hauser, Claudia Schulte, Walter Maetzler, Thomas Gasser, Daniela Berg, GBA-associated Parkinson's disease: Reduced survival and more rapid progression in a prospective longitudinal study, Movement Disorders, 2015, 30, 3
  9. 9
    R. N. Alcalay, O. A. Levy, C. C. Waters, S. Fahn, B. Ford, S.-H. Kuo, P. Mazzoni, M. W. Pauciulo, W. C. Nichols, Z. Gan-Or, G. A. Rouleau, W. K. Chung, P. Wolf, P. Oliva, J. Keutzer, K. Marder, X. Zhang, Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations, Brain, 2015,

    CrossRef

  10. 10
    Anthony H.V. Schapira, Glucocerebrosidase and Parkinson disease: Recent advances, Molecular and Cellular Neuroscience, 2015, 66, 37

    CrossRef

  11. 11
    Carmen Noelker, Lixia Lu, Matthias Höllerhage, Franca Vulinovic, Annekathrin Sturn, René Roscher, Günter U. Höglinger, Etienne C. Hirsch, Wolfgang H. Oertel, Daniel Alvarez-Fischer, Hartmann Andreas, Glucocerebrosidase deficiency and mitochondrial impairment in experimental Parkinson disease, Journal of the Neurological Sciences, 2015,

    CrossRef

  12. 12
    Eun-Jin Bae, Na Young Yang, Cheolsoon Lee, He-Jin Lee, Seokjoong Kim, Sergio Pablo Sardi, Seung-Jae Lee, Loss of glucocerebrosidase 1 activity causes lysosomal dysfunction and α-synuclein aggregation, Experimental & Molecular Medicine, 2015, 47, 3, e153

    CrossRef

  13. 13
    A. McNeill, Lysosomal dysfunction in Parkinson's disease, Brain, 2015, 138, 4, e339

    CrossRef

  14. 14
    Ole Isacson, Lysosomes to combat Parkinson's disease, Nature Neuroscience, 2015, 18, 6, 792

    CrossRef

  15. 15
    Su Melser, Julie Lavie, Giovanni Bénard, Mitochondrial degradation and energy metabolism, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2015,

    CrossRef

  16. 16
    B. T. Adams, S. Niccoli, M. A. Chowdhury, A. N. K. Esarik, S. J. Lees, B. P. Rempel, C. P. Phenix, N-Alkylated aziridines are easily-prepared, potent, specific and cell-permeable covalent inhibitors of human β-glucocerebrosidase, Chem. Commun., 2015, 51, 57, 11390

    CrossRef

  17. 17
    Matthew E. Gegg, Lindsay Sweet, Bing H. Wang, Lamya S. Shihabuddin, Sergio Pablo Sardi, Anthony H.V. Schapira, No evidence for substrate accumulation in Parkinson brains with GBA mutations, Movement Disorders, 2015, 30, 7
  18. 18
    Stephen Mullin, Anthony H.V. Schapira, Pathogenic Mechanisms of Neurodegeneration in Parkinson Disease, Neurologic Clinics, 2015, 33, 1, 1

    CrossRef

  19. 19
    Evgenii Nuzhnyi, Anton Emelyanov, Tatyana Boukina, Tatiana Usenko, Andrey Yakimovskii, Ekaterina Zakharova, Sofya Pchelina, Plasma Oligomeric Alpha-Synuclein Is Associated With Glucocerebrosidase Activity in Gaucher Disease, Movement Disorders, 2015, 30, 7
  20. 20
    Emily M. Rocha, Gaynor A. Smith, Eric Park, Hongmei Cao, Eilish Brown, Penelope Hallett, Ole Isacson, Progressive decline of glucocerebrosidase in aging and Parkinson's disease, Annals of Clinical and Translational Neurology, 2015, 2, 4
  21. 21
    Davide Chiasserini, Silvia Paciotti, Paolo Eusebi, Emanuele Persichetti, Anna Tasegian, Marzena Kurzawa-Akanbi, Patrick F Chinnery, Christopher M Morris, Paolo Calabresi, Lucilla Parnetti, Tommaso Beccari, Selective loss of glucocerebrosidase activity in sporadic Parkinson’s disease and dementia with Lewy bodies, Molecular Neurodegeneration, 2015, 10, 1

    CrossRef

  22. 22
    Franziska Richter, Sheila M. Fleming, Melanie Watson, Vincent Lemesre, Lee Pellegrino, Brian Ranes, Chunni Zhu, Farzad Mortazavi, Caitlin K. Mulligan, Pedrom C. Sioshansi, Sindalana Hean, Krystal De La Rosa, Richie Khanna, John Flanagan, David J. Lockhart, Brandon A. Wustman, Sean W. Clark, Marie-Françoise Chesselet, A GCase Chaperone Improves Motor Function in a Mouse Model of Synucleinopathy, Neurotherapeutics, 2014, 11, 4, 840

    CrossRef

  23. 23
    Sarah K. Abbott, Hongyun Li, Sonia Sanz Muñoz, Bianca Knoch, Marijka Batterham, Karen E. Murphy, Glenda M. Halliday, Brett Garner, Altered ceramide acyl chain length and ceramide synthase gene expression in Parkinson's disease, Movement Disorders, 2014, 29, 4
  24. 24
    A. McNeill, J. Magalhaes, C. Shen, K.-Y. Chau, D. Hughes, A. Mehta, T. Foltynie, J. M. Cooper, A. Y. Abramov, M. Gegg, A. H. V. Schapira, Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells, Brain, 2014, 137, 5, 1481

    CrossRef

  25. 25
    Elena Antelmi, Giovanni Rizzo, Margherita Fabbri, Sabina Capellari, Cesa Scaglione, Paolo Martinelli, Arylsulphatase A activity in familial parkinsonism: a pathogenetic role?, Journal of Neurology, 2014, 261, 9, 1803

    CrossRef

  26. 26
    I. Fishbein, Y.-M. Kuo, B. I. Giasson, R. L. Nussbaum, Augmentation of phenotype in a transgenic Parkinson mouse heterozygous for a Gaucher mutation, Brain, 2014, 137, 12, 3235

    CrossRef

  27. 27
    Michael P Nelson, Tonia E Tse, Darrel B O’Quinn, Stefanie M Percival, Edgar A Jaimes, David G Warnock, John J Shacka, Autophagy-lysosome pathway associated neuropathology and axonal degeneration in the brains of alpha-galactosidase A-deficient mice, Acta Neuropathologica Communications, 2014, 2, 1, 20

    CrossRef

  28. 28
    Lucilla Parnetti, Davide Chiasserini, Emanuele Persichetti, Paolo Eusebi, Shiji Varghese, Mohammad M. Qureshi, Andrea Dardis, Marta Deganuto, Claudia Carlo, Anna Castrioto, Chiara Balducci, Silvia Paciotti, Nicola Tambasco, Bruno Bembi, Laura Bonanni, Marco Onofrj, Aroldo Rossi, Tommaso Beccari, Omar El-Agnaf, Paolo Calabresi, Cerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson's disease, Movement Disorders, 2014, 29, 8
  29. 29
    Chaodong Wang, Yanning Cai, Zhuqin Gu, Jinghong Ma, Zheng Zheng, Bei-Sha Tang, Yanming Xu, Yongtao Zhou, Tao Feng, Tao Wang, Sheng-Di Chen, Piu Chan, Clinical profiles of Parkinson's disease associated with common leucine-rich repeat kinase 2 and glucocerebrosidase genetic variants in Chinese individuals, Neurobiology of Aging, 2014, 35, 3, 725.e1

    CrossRef

  30. 30
    Robert E. Boyd, Kenneth J. Valenzano, Correction of lysosomal dysfunction as a therapeutic strategy for neurodegenerative diseases, Bioorganic & Medicinal Chemistry Letters, 2014, 24, 14, 3001

    CrossRef

  31. 31
    Eun-Jin Bae, Na-Young Yang, Miyoung Song, Cheol Soon Lee, Jun Sung Lee, Byung Chul Jung, He-Jin Lee, Seokjoong Kim, Eliezer Masliah, Sergio Pablo Sardi, Seung-Jae Lee, Glucocerebrosidase depletion enhances cell-to-cell transmission of α-synuclein, Nature Communications, 2014, 5, 4755

    CrossRef

  32. 32
    M. Siebert, E. Sidransky, W. Westbroek, Glucocerebrosidase is shaking up the synucleinopathies, Brain, 2014, 137, 5, 1304

    CrossRef

  33. 33
    N. Dzamko, C.L Geczy, G.M Halliday, Inflammation is genetically implicated in Parkinson’s disease, Neuroscience, 2014,

    CrossRef

  34. 34
    Chris M. Woodard, Brian A. Campos, Sheng-Han Kuo, Melissa J. Nirenberg, Michael W. Nestor, Matthew Zimmer, Eugene V. Mosharov, David Sulzer, Hongyan Zhou, Daniel Paull, Lorraine Clark, Eric E. Schadt, Sergio Pablo Sardi, Lee Rubin, Kevin Eggan, Mathew Brock, Scott Lipnick, Mahendra Rao, Stephen Chang, Aiqun Li, Scott A. Noggle, iPSC-Derived Dopamine Neurons Reveal Differences between Monozygotic Twins Discordant for Parkinson’s Disease, Cell Reports, 2014, 9, 4, 1173

    CrossRef

  35. 35
    David C. Schöndorf, Massimo Aureli, Fiona E. McAllister, Christopher J. Hindley, Florian Mayer, Benjamin Schmid, S. Pablo Sardi, Manuela Valsecchi, Susanna Hoffmann, Lukas Kristoffer Schwarz, Ulrike Hedrich, Daniela Berg, Lamya S. Shihabuddin, Jing Hu, Jan Pruszak, Steven P. Gygi, Sandro Sonnino, Thomas Gasser, Michela Deleidi, iPSC-derived neurons from GBA1-associated Parkinson’s disease patients show autophagic defects and impaired calcium homeostasis, Nature Communications, 2014, 5,

    CrossRef

  36. 36
    Alisdair McNeill, Is elevated beta-hexosaminidase activity a potential biomarker for Parkinson's disease?, Movement Disorders, 2014, 29, 10
  37. 37
    M. Rothaug, F. Zunke, J. R. Mazzulli, M. Schweizer, H. Altmeppen, R. Lullmann-Rauch, W. W. Kallemeijn, P. Gaspar, J. M. Aerts, M. Glatzel, P. Saftig, D. Krainc, M. Schwake, J. Blanz, LIMP-2 expression is critical for  -glucocerebrosidase activity and  -synuclein clearance, Proceedings of the National Academy of Sciences, 2014, 111, 43, 15573

    CrossRef

  38. 38
    Ashley Gonzalez, Mark Valeiras, Ellen Sidransky, Nahid Tayebi, Lysosomal integral membrane protein-2: A new player in lysosome-related pathology, Molecular Genetics and Metabolism, 2014, 111, 2, 84

    CrossRef

  39. 39
    E. Aflaki, B. K. Stubblefield, E. Maniwang, G. Lopez, N. Moaven, E. Goldin, J. Marugan, S. Patnaik, A. Dutra, N. Southall, W. Zheng, N. Tayebi, E. Sidransky, Macrophage Models of Gaucher Disease for Evaluating Disease Pathogenesis and Candidate Drugs, Science Translational Medicine, 2014, 6, 240, 240ra73

    CrossRef

  40. 40
    Gerald Stern, Niemann–Pick's and Gaucher's diseases, Parkinsonism & Related Disorders, 2014, 20, S143

    CrossRef

  41. You have free access to this content41
    L D Osellame, M R Duchen, Quality control gone wrong: mitochondria, lysosomal storage disorders and neurodegeneration, British Journal of Pharmacology, 2014, 171, 8
  42. 42
    Steven Lubbe, Huw R. Morris, Recent advances in Parkinson’s disease genetics, Journal of Neurology, 2014, 261, 2, 259

    CrossRef

  43. 43
    K. E. Murphy, A. M. Gysbers, S. K. Abbott, N. Tayebi, W. S. Kim, E. Sidransky, A. Cooper, B. Garner, G. M. Halliday, Reduced glucocerebrosidase is associated with increased  -synuclein in sporadic Parkinson's disease, Brain, 2014, 137, 3, 834

    CrossRef

  44. 44
    Anthony H V Schapira, C Warren Olanow, J Timothy Greenamyre, Erwan Bezard, Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives, The Lancet, 2014, 384, 9942, 545

    CrossRef

  45. 45
    Kathrin Brockmann, Daniela Berg, The significance of GBA for Parkinson’s disease, Journal of Inherited Metabolic Disease, 2014, 37, 4, 643

    CrossRef

  46. 46
    P. J. Schultheis, S. M. Fleming, A. K. Clippinger, J. Lewis, T. Tsunemi, B. Giasson, D. W. Dickson, J. R. Mazzulli, M. E. Bardgett, K. L. Haik, O. Ekhator, A. K. Chava, J. Howard, M. Gannon, E. Hoffman, Y. Chen, V. Prasad, S. C. Linn, R. J. Tamargo, W. Westbroek, E. Sidransky, D. Krainc, G. E. Shull, Atp13a2-deficient mice exhibit neuronal ceroid lipofuscinosis, limited  -synuclein accumulation and age-dependent sensorimotor deficits, Human Molecular Genetics, 2013, 22, 10, 2067

    CrossRef

  47. 47
    S. Pablo Sardi, Jennifer Clarke, Catherine Viel, Monyrath Chan, Thomas J. Tamsett, Christopher M. Treleaven, Jie Bu, Lindsay Sweet, Marco A. Passini, James C. Dodge, W. Haung Yu, Richard L. Sidman, Seng H. Cheng, Lamya S. Shihabuddin, Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies, Proceedings of the National Academy of Sciences, 2013, 110, 9, 3537

    CrossRef

  48. 48
    Lucilla Parnetti, Anna Castrioto, Davide Chiasserini, Emanuele Persichetti, Nicola Tambasco, Omar El-Agnaf, Paolo Calabresi, Cerebrospinal fluid biomarkers in Parkinson disease, Nature Reviews Neurology, 2013, 9, 3, 131

    CrossRef

  49. 49
    Karin D. Dijk, Emanuele Persichetti, Davide Chiasserini, Paolo Eusebi, Tommaso Beccari, Paolo Calabresi, Henk W. Berendse, Lucilla Parnetti, Wilma D. J. Berg, Changes in endolysosomal enzyme activities in cerebrospinal fluid of patients with Parkinson's disease, Movement Disorders, 2013, 28, 6
  50. 50
    Anthony H. V. Schapira, Matthew E. Gegg, Glucocerebrosidase in the pathogenesis and treatment of Parkinson disease: Fig. 1., Proceedings of the National Academy of Sciences, 2013, 110, 9, 3214

    CrossRef

  51. 51
    Michelle S. Beavan, Anthony H. V. Schapira, Glucocerebrosidase mutations and the pathogenesis of Parkinson disease, Annals of Medicine, 2013, 45, 8, 511

    CrossRef

  52. 52
    Derek G. Burke, Ahad A. Rahim, Simon N. Waddington, Stefan Karlsson, Ida Enquist, Kailash Bhatia, Atul Mehta, Ashok Vellodi, Simon Heales, Increased glucocerebrosidase (GBA) 2 activity in GBA1 deficient mice brains and in Gaucher leucocytes, Journal of Inherited Metabolic Disease, 2013, 36, 5, 869

    CrossRef

  53. 53
    Thai Leong Yap, Arash Velayati, Ellen Sidransky, Jennifer C. Lee, Membrane-bound α-synuclein interacts with glucocerebrosidase and inhibits enzyme activity, Molecular Genetics and Metabolism, 2013, 108, 1, 56

    CrossRef

  54. 54
    Laura D. Osellame, Ahad A. Rahim, Iain P. Hargreaves, Matthew E. Gegg, Angela Richard-Londt, Sebastian Brandner, Simon N. Waddington, Anthony H.V. Schapira, Michael R. Duchen, Mitochondria and Quality Control Defects in a Mouse Model of Gaucher Disease—Links to Parkinson’s Disease, Cell Metabolism, 2013, 17, 6, 941

    CrossRef

  55. 55
    David T. Dexter, Peter Jenner, Parkinson disease: from pathology to molecular disease mechanisms, Free Radical Biology and Medicine, 2013, 62, 132

    CrossRef

  56. 56
    Tom Foltynie, Joshua Kahan, Parkinson’s disease: an update on pathogenesis and treatment, Journal of Neurology, 2013, 260, 5, 1433

    CrossRef

  57. 57
    Anthony H.V. Schapira, Recent developments in biomarkers in Parkinson disease, Current Opinion in Neurology, 2013, 26, 4, 395

    CrossRef

  58. 58
    Thai Leong Yap, James M. Gruschus, Arash Velayati, Ellen Sidransky, Jennifer C. Lee, Saposin C Protects Glucocerebrosidase against α-Synuclein Inhibition, Biochemistry, 2013, 52, 41, 7161

    CrossRef

  59. 59
    Matthew Swan, Rachel Saunders-Pullman, The Association Between ß-Glucocerebrosidase Mutations and Parkinsonism, Current Neurology and Neuroscience Reports, 2013, 13, 8

    CrossRef

  60. 60
    Raquel Duran, Niccolo E. Mencacci, Aikaterini V. Angeli, Maryam Shoai, Emma Deas, Henry Houlden, Atul Mehta, Derralynn Hughes, Timothy M. Cox, Patrick Deegan, Anthony H. Schapira, Andrew J. Lees, Patricia Limousin, Paul R. Jarman, Kailash P. Bhatia, Nicholas W. Wood, John Hardy, Tom Foltynie, The glucocerobrosidase E326K variant predisposes to Parkinson's disease, but does not cause Gaucher's disease, Movement Disorders, 2013, 28, 2
  61. 61
    Stephen Mullin, Anthony Schapira, α-Synuclein and Mitochondrial Dysfunction in Parkinson’s Disease, Molecular Neurobiology, 2013, 47, 2, 587

    CrossRef